Jemperli (Dostarlimab) | Relatório de avaliação de financiamento público disponível na Infomed | Deferimento Infarmed

Jemperli (Dostarlimab) | Relatório de avaliação de financiamento público disponível na Infomed | Deferimento

Aceda à notícia na íntegra: 🔗 swki.me/R74wiWd4
#infarmed #jemperli #medicamentos #financiamentopúblico

GSK子会社TESARO、ドスタルリマブを巡りAnaptysBioを提訴 契約違反によりライセンス終了を主張 | STELLANEWS.LIFE TESARO（GSKの子会社）は、がん免疫薬ドスタルリマブ（商品名ジェンペルリ）のライセンス契約を巡り、AnaptysBioに対する訴訟をデラウェア衡平法裁判所で開始した。TESARO側は契約違反を主張し、永久的な使用権獲得とロイヤルティ支払いの半減を求めている。AnaptysBioによるライセンス取り消しの主張に対しては、根拠がないと反論している。

TESARO, a GSK subsidiary, sues AnaptysBio over the dostarlimab (Jemperli) license agreement.

🔗 Full article: stellanews.life/technology_c...

#GSK #TESARO #AnaptysBio #Jemperli #Dostarlimab #LegalDispute #Oncology #Immunotherapy #Pharma

【GSK子会社TESARO、ドスタルリマブを巡りAnaptysBioを提訴】
GSKの子会社TESAROが、がん免疫療法薬ドスタルリマブ（Jemperli）に関するライセンス契約違反を理由に、AnaptysBioを提訴したと発表。

#GSK #TESARO #AnaptysBio #Jemperli #ドスタルリマブ #がん免疫療法 #契約訴訟 #バイオ医薬品 #ライセンス契約

Emma Walmsley upholds £40B sales target in her final GSK CEO report Emma Walmsley and her GSK CEO successor, Luke Miels, are safeguarding the British pharma’s 40 billion-pound-sterling sales projection for 2031 on the back of a strong quarter. | Emma Walmsley and her ...

#GSK #EmmaWalmsley #LukeMiels #Blenrep #Arexvy #Shingrix #multiplemyeloma #PD1inhibitor #Jemperli #rectalcancer #antibodydrugconjugates #ADCs #HansohPharma #FDAapproval #longactingbiologic #depemokima #chronicrhinosinusitis #biologics #vaccines #shinglesvaccine #RSVvaccine
zurl.co/iumHW

Dostarlimab (Jemperli) 2025 Updates: What Patients Need to Know? - OncoDaily Learn more about Dostarlimab (Jemerli), its uses, dosage, side effects, and what patients should expect during treatment.

Dostarlimab (Jemperli) 2025 Updates: What Patients Need to Know?

oncodaily.com/drugs/dostar...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Dostarlimab #Jemperli #EndometrialCancer #FDAapprovals #Immunotherapy

Dostarlimab (Jemperli) 2025 Updates: Uses in Cancer, Side Effects, Dosage, Expectations, and More - OncoDaily Learn more about dostarlimab (jemerli), its uses in cancer treatment, side effects, dosage and what to expect.

Dostarlimab (Jemperli) 2025 Updates: Uses in Cancer, Side Effects, Dosage, Expectations, and More

oncodaily.com/drugs/dostar...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Dostarlimab #Jemperli #EndometrialCancer #Immunotherapy

📌 OncoTerm - Word of the Day! 👋 OncoTerm - Günün Kelimesi! 📌

Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.

#Onco404 #Cancer #Kanser #MedSky #ImmuneCheckpointInhibitor #Immunotherapy #Keytruda #Opdivo #Yervoy #Imfinzi #Jemperli #Vocabulary

Cancer Breakthrough? Jemperli vs. Surgery for Some Patients A new study announces exciting results for certain solid tumors. Is Jemperli a cancer breakthrough? If the cancers are "dMMR," quite possibly!

Cancer Breakthrough? Jemperli vs. Surgery for Some Patients www.peoplespharmacy.com/articles/can... via @peoplespharmacy

#cancer #dMMR #Jemperli #surgery #cancerbreakthrough #health

GSK’s Jemperli is changing the game for rectal cancer treatment! A 100% response rate without chemo or surgery—this is huge. Follow for more updates! #CancerTreatment #MedicalBreakthrough #FDAApproval #Cancer #CancerResearch #RectalCancer #Tumor #Oncology #Jemperli #FDA #HealthNews #PharmaNews